Pulmonary Vein Isolation

In a small, single-center trial, the novel Marshall-Plan ablation strategy improved 10-month arrhythmia recurrence compared with pulmonary vein isolation alone for persistent atrial fibrillation, a speaker reported.

Pulsed field ablation pulmonary vein isolation for atrial fibrillation may confer less damage to cardiac nerves and ganglia vs. cryoballoon ablation, researchers reported.

Comparing procedural time between conventional pulmonary vein isolation vs. very high-power radiofrequency delivery in AF patients.

Evaluating the reliability of the Electrographic Flow algorithm technology (Ablacon) to identify atrial fibrillation sources and guide ablation therapy in patients with persistent AF.

Radiofrequency ablation technique was not associated with any difference in atrial fibrillation recurrence after redo ablation despite durable initial pulmonary vein isolation, researchers reported.

In a real-world setting, a novel cryoballoon for atrial fibrillation ablation generated effective pulmonary vein isolation with relatively short procedure times, researchers reported.

Very high-power, short-duration ablation for PVI utilizing a novel catheter with a very close protocol vs. conventional contact force sensing AI-guided radiofrequency ablation.

Effect of posterior wall isolation added to pulmonary vein isolation on freedom from AF.

Electrographic flow-guided ablation was associated with improvement in freedom from atrial fibrillation at 1 year compared with standard pulmonary vein isolation in patients with nonparoxysmal AF requiring a redo ablation, data showed.

A novel catheter for very high-power short-duration ablation for pulmonary vein isolation in patients with atrial fibrillation modestly reduced procedure time compared with standard ablation, according to data from the POWER PLUS trial.